Tag: CX 2017

Registry shows better patency and fewer reinterventions for Aperto drug-coated balloon...

Drug-coated balloon treatment for vascular access stenosis offers a real alternative to plain balloon angioplasty, reducing the rate of reinterventions and prolonging the lifespan of...

Vonapanitase associated with increased fistula survival and haemodialysis use

Data from the PATENCY-1 trial indicate that the application of vonapanitase (Proteon Therapeutics) at the time of fistula surgery is associated with increased fistula...

Six-month LOCOMOTIVE Registry outcomes presented

At the 2017 Charing Cross Symposium (25–28 April, London, UK) Klaus Amendt presented six-month outcomes from the all-comers LOCOMOTIVE Registry, which is investigating the...

The relationship between aortic arch interventions and acute stroke

At the 2017 Charing Cross Symposium (25–28 April, London, UK), speakers and panellists discussed the challenges of endovascular aortic arch procedures and their potential...

Lombard Medical’s endovascular product portfolio presented at 2017 Charing Cross Symposium

Lombard Medical’s portfolio of endovascular stent graft systems, Altura and Aorfix, were featured in scientific presentations at the 39th annual Charing Cross International Symposium (CX;...

Stent fatigue mathematical modelling research wins CX Selected Posters Session

Twelve posters selected for presentation out of 68 posters displayed were carefully reviewed by the CX Abstract Board, who decided to award their prize...

“Fantastic” new Venous City offers “dynamic, informative” hands-on education

The CX Venous Workshop returned on Wednesday, bigger than ever before. With a new location in the Exhibition Hall and its own series of...

Spotlight on non-thermal varicose vein treatments in first-ever CX Venous Edited...

For the first time, Day One of this year’s CX Venous Workshop included two edited case presentations (CX Venous Edited Cases). The standing-room only...

Screening women for abdominal aortic aneurysm would yield little benefit and...

First-time data presentation from the SWAN (Screening Women for Abdominal aNeurysms) project was heard at the 2017 Charing Cross Symposium (CX; 25–28 April, London, UK). The...

EVAR 2 very long-term results prompt a call for shared decision-making...

A “podium first” presentation of very long-term follow-up data from the EVAR 2 trials suggests that endovascular aneurysm repair (EVAR) fails to improve all-cause...

CX audience homes in on grey area between drug-coated balloons and...

At the 2017 Charing Cross Symposium (CX; 25–28 April, London, UK), delegates heard brand new data for drug-coated balloons (DCBs) in “wider use” scenarios...

Watch and learn: CX Aortic Edited Cases

Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the...

Remembering that “babies are not little adults” at CX Paediatric Vascular...

The particular complexities of dealing with paediatric vessels were discussed in depth at Tuesday’s varied and informative CX Paediatric Vascular Emergencies and Case Presentations...

Approaching vascular malformations

In Tuesday’s CX Congenital Vascular Malformations session, delegates heard about how approaching congenital vascular malformations with systematic pathways of care and classification systems can...